April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
THE MACCABI GLAUCOMA STUDY- TREATMENT PATTERNS AND PERSISTENCE WITH GLAUCOMA THERAPY IN A LARGE ISRAELI HEALTH MAINTENANCE ORGANIZATION
Author Affiliations & Notes
  • Hani Levkovitch-Verbin
    Ophthalmology, Maccabi Health Services, Tel-Aviv, Israel
    Ophthalmology, Goldschleger Eye Institute, Tel-Hashomer, Israel
  • Varda Shalev
    Ophthalmology, Maccabi Health Services, Tel-Aviv, Israel
  • Nir Zigman
    Ophthalmology, Maccabi Health Services, Tel-Aviv, Israel
  • Gabriel Chodick
    Ophthalmology, Maccabi Health Services, Tel-Aviv, Israel
  • Inbal Goldschtein
    Ophthalmology, Maccabi Health Services, Tel-Aviv, Israel
  • Footnotes
    Commercial Relationships Hani Levkovitch-Verbin, None; Varda Shalev, None; Nir Zigman, None; Gabriel Chodick, None; Inbal Goldschtein, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4318. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hani Levkovitch-Verbin, Varda Shalev, Nir Zigman, Gabriel Chodick, Inbal Goldschtein; THE MACCABI GLAUCOMA STUDY- TREATMENT PATTERNS AND PERSISTENCE WITH GLAUCOMA THERAPY IN A LARGE ISRAELI HEALTH MAINTENANCE ORGANIZATION. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4318.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To characterize adherence and persistence to glaucoma medications among glaucoma patients in Israel

 
Methods
 

This is a population-based retrospective cohort study, conducted using the electronic medical databases of Maccabi Healthcare Services (MHS), a 2 million member health maintenance organization in Israel. All MHS newly diagnosed glaucoma patients who purchased at least one anti-glaucoma medication were included. Collected data included demographics, baseline intraocular pressure, diagnosis, prescribed and dispensed anti-glaucoma medications, and caregiver characteristics. Adherence was analyzed by proportion of days covered by drugs during follow up time, ignoring overlaps due to overuse and simultaneous combination of several types of eye drops.

 
Results
 

We identified a total of 5,934 incident definite glaucoma patients, who were diagnosed between 2003 and 2010 and purchased at least one anti-glaucoma medication. The mean medical coverage was 58%. Thirteen percent were non-adherent with therapy (covered less than 20% of the follow up time), and only 25% exhibited high adherence (covered at least 80% of the follow-up period). Medical coverage was affected significantly by patient age, gender, socioeconomic status, diagnosis and IOP at baseline. Patients with angle closure and low tension glaucoma were less persistent than those with open angle and exfoliation glaucoma. Medical coverage was also affected by class of drug.

 
Conclusions
 

Every Israeli citizen is covered by a governmental supported health insurance. Nevertheless, this study confirms that adherence and persistence with ocular hypotensive medications is less than ideal among Israeli glaucoma patients. Both patients and caregiver characteristics affect adherence.

 
Keywords: 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • 462 clinical (human) or epidemiologic studies: outcomes/complications • 463 clinical (human) or epidemiologic studies: prevalence/incidence  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×